BCL2 and cancer: In these cancer tissues, the expression of Mcl-1 was the highest, followed by Bcl-xL and Bcl-2, further justifying the co-targeting of Bcl-xL/Mcl-1 rather than Bcl-2/Mcl-1 (27).